Shares of ​Kodiak Sciences surged 68.6% to their highest in more than ​four years on Thursday after the drug developer's experimental drug met the main goal in a late-stage study in patients with diabetes-related eye damage.

Nifty extended gains for a second session, led by banks, auto and consumer stocks amid easing Middle East tensions. Analysts see bullish momentum sustaining above key support, with upside potential if resistance levels are crossed, while highlighting selective stock buying opportunities.

The Vadodara civic body is aiming to raise another Rs 200 crore through the municipal bonds route by July this year, people familiar with the development have said.

Wall Street stocks opened lower as oil prices surged, fueled by escalating tensions between the US and Iran and a lack of immediate peace prospects. Investors are concerned about the economic impact of high oil prices, while memory chip manufacturers faced declines following new AI research.